{"title":"GLP-1 Research Peptides","description":"\u003cp\u003eOptic Labs supplies incretin-class research peptides in Australia, including \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e, \u003ca href=\"\/products\/tirzepatide-10mg\"\u003eTirzepatide\u003c\/a\u003e and \u003ca href=\"\/products\/semaglutide-5mg\"\u003eSemaglutide\u003c\/a\u003e. Every batch is third-party HPLC tested, and the Certificates of Analysis are published in our \u003ca href=\"\/pages\/labreport\"\u003eCOA library\u003c\/a\u003e. Orders are dispatched within Australia from Sydney, NSW.\u003c\/p\u003e\n\u003ch2\u003eSingle, dual and triple receptor agonists\u003c\/h2\u003e\n\u003cp\u003eThese compounds are commonly compared by their receptor profile. \u003cstrong\u003eSemaglutide\u003c\/strong\u003e is studied as a single GLP-1 receptor agonist. \u003cstrong\u003eTirzepatide\u003c\/strong\u003e is studied as a dual GIP \/ GLP-1 receptor agonist. \u003cstrong\u003eRetatrutide\u003c\/strong\u003e is studied as a triple agonist that also acts at the glucagon receptor. Researchers often study them side by side in comparative receptor-pharmacology work. For background, see our \u003ca href=\"\/blogs\/news\/retatrutide-australia-triple-agonist-guide\"\u003eRetatrutide research guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch2\u003eHandling and reconstitution\u003c\/h2\u003e\n\u003cp\u003eAll three are supplied as lyophilised powder in sealed research vials and are reconstituted with \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. Use our free \u003ca href=\"\/pages\/peptide-calculator\"\u003epeptide calculator\u003c\/a\u003e for concentration maths, and store vials at 2–8°C away from light.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAll products are supplied for laboratory research use only and are not for human consumption.\u003c\/em\u003e\u003c\/p\u003e","products":[{"product_id":"semaglutide-5mg","title":"Semaglutide 5mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Semaglutide 5mg in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat is Semaglutide?\u003c\/strong\u003e Semaglutide is a synthetic long-acting agonist of the GLP-1 receptor — a 31-amino-acid analogue of human GLP-1 modified to extend its half-life. In published research it is studied for GLP-1 receptor signalling, glycaemic control and body composition. Optic Labs supplies HPLC-tested Semaglutide (\u0026gt;99% purity) as a lyophilised 5mg powder vial for laboratory research use only, dispatched Australia-wide from Sydney.\u003c\/p\u003e\n\n\u003ch2\u003eAbout Semaglutide\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a synthetic 31-amino-acid peptide developed by Novo Nordisk as a long-acting agonist of the glucagon-like peptide-1 receptor (GLP-1R). Structurally, it is an analogue of native human GLP-1(7–37) with substitutions at positions 8 and 34 and a fatty-acid side-chain attached via a linker at position 26 — modifications that extend its half-life relative to native GLP-1. Optic Labs supplies semaglutide as a high-purity lyophilised powder in 5mg vials, packaged for in vitro and preclinical laboratory research.\u003c\/p\u003e\n\n\u003cp\u003eEach batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eSemaglutide is one of the most extensively studied compounds in modern metabolic research, with published Phase 3 clinical trial data examining glycaemic control and body composition across multiple programmes. Optic Labs supplies semaglutide for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Semaglutide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 910463-68-2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e 31 amino acids (modified GLP-1[7–37] analogue with C18 fatty-acid side chain)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e187\u003c\/sub\u003eH\u003csub\u003e291\u003c\/sub\u003eN\u003csub\u003e45\u003c\/sub\u003eO\u003csub\u003e59\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~4113.6 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism (research context):\u003c\/strong\u003e Single agonist — GLP-1R\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 5mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eSemaglutide was developed as a long-acting GLP-1 receptor agonist following earlier short-acting GLP-1 analogues. Published preclinical and clinical research has examined semaglutide in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1 receptor binding, signalling and downstream pathways\u003c\/li\u003e\n\u003cli\u003eGlycaemic control and insulin sensitivity in type 2 diabetes research models\u003c\/li\u003e\n\u003cli\u003eBody composition and adiposity in animal models and clinical study populations\u003c\/li\u003e\n\u003cli\u003eGastric emptying and appetite-regulation research\u003c\/li\u003e\n\u003cli\u003eCardiovascular outcomes research in clinical study programmes (SUSTAIN, SELECT)\u003c\/li\u003e\n\u003cli\u003ePhase 1, 2 and 3 clinical pharmacokinetic, glycaemic and weight-change studies (SUSTAIN, STEP programmes)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A 5mg vial reconstituted in 1mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 5mg\/mL; 2mL yields 2.5mg\/mL.\u003c\/p\u003e\n\n\u003cp\u003eExact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eComparisons and related research compounds\u003c\/h2\u003e\n\u003cp\u003eSemaglutide sits within the broader class of incretin and metabolic peptides. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tirzepatide-10mg\"\u003eTirzepatide\u003c\/a\u003e — dual GLP-1 + GIP agonist, second-generation incretin research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e — triple agonist (GLP-1 + GIP + glucagon), third-generation incretin research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — fragment growth-hormone analogue, fat-loss research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — GHRH analogue, lipolysis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor, metabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs semaglutide legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is registered with the Therapeutic Goods Administration (TGA) as a Schedule 4 prescription-only therapeutic medicine in Australia under separate brand registrations. Optic Labs does not supply semaglutide as a therapeutic, prescription or compounded product, and semaglutide from Optic Labs is not intended for personal, clinical or therapeutic use. Optic Labs supplies semaglutide strictly as a research-grade material for in vitro and preclinical laboratory research only. For a detailed overview of peptide legality in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is semaglutide?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a synthetic GLP-1 receptor agonist — a 31-amino-acid peptide modified from native human GLP-1 with substitutions and a fatty-acid side chain that extend its half-life. In published research it has been investigated for its effects on glycaemic control, body composition, hepatic lipid metabolism, gastric emptying and cardiovascular endpoints.\u003c\/p\u003e\n\n\u003ch3\u003eHow does semaglutide differ from tirzepatide and retatrutide?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a single GLP-1 receptor agonist. \u003ca href=\"\/products\/tirzepatide-10mg\"\u003eTirzepatide\u003c\/a\u003e is a dual GLP-1 + GIP agonist. \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e adds a third receptor target — the glucagon receptor — making it a triple agonist. The published research literature has examined each compound across its own clinical programme, and the receptor profiles differ in mechanism rather than being directly interchangeable.\u003c\/p\u003e\n\n\u003ch3\u003eHow is semaglutide supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies semaglutide as a lyophilised powder in a sealed glass research vial at the 5mg size. Each vial is shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a semaglutide 5mg vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a starting reference: 5mg in 1mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 5mg\/mL; 5mg in 2mL yields 2.5mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted semaglutide be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":51430827393249,"sku":null,"price":79.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0867\/4076\/2849\/files\/hf_20260522_095136_47fe6b0b-7757-49de-9a4a-7d86258dba82.png?v=1794295892"},{"product_id":"retatrutide-5mg-10mg-15mg-20mg-30mg-60mg","title":"Retatrutide 5mg \/ 10mg \/ 15mg \/ 20mg \/ 30mg \/ 60mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Retatrutide in Australia (5mg, 10mg, 15mg, 20mg, 30mg and 60mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat is Retatrutide?\u003c\/strong\u003e Retatrutide (LY3437943) is a synthetic peptide studied as a triple agonist of the GIP, GLP-1 and glucagon receptors — a single molecule acting at three metabolic receptors at once. Optic Labs supplies HPLC-tested Retatrutide (\u0026gt;99% purity) as a lyophilised powder in 5mg to 60mg vials for laboratory research use only, dispatched Australia-wide from Sydney.\u003c\/p\u003e\n\n\u003ch2\u003eAbout Retatrutide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide (LY3437943) is a synthetic peptide studied as a triple agonist of the GIP, GLP-1 and glucagon receptors. Its single-molecule, three-receptor profile has made it one of the most closely followed compounds in current incretin and metabolic receptor research.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies Retatrutide as a lyophilised (freeze-dried) powder in sealed research vials, distributed Australian-domestic from Sydney, NSW. Every batch is independently HPLC tested, and the Certificate of Analysis is published in our \u003ca href=\"\/pages\/labreport\"\u003eCOA library\u003c\/a\u003e. The product is supplied strictly for laboratory research, development or analytical use, not for human or veterinary administration.\u003c\/p\u003e\n\n\u003ch2\u003eRetatrutide sizes available in Australia\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is available in six vial sizes: \u003cstrong\u003e5mg, 10mg, 15mg, 20mg, 30mg and 60mg\u003c\/strong\u003e. Larger vials suit longer research programmes and reduce the number of vials to reconstitute and track.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Retatrutide (LY3437943)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClass:\u003c\/strong\u003e GIP \/ GLP-1 \/ glucagon receptor triple agonist peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder in sealed research vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% (third-party HPLC, COA available)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 5mg, 10mg, 15mg, 20mg, 30mg, 60mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (lyophilised):\u003c\/strong\u003e 2–8°C, protected from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (reconstituted):\u003c\/strong\u003e 2–8°C, used within approximately 28 days\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReceptor profile:\u003c\/strong\u003e Retatrutide is studied for its activity at three receptors at once (GIP, GLP-1 and glucagon), whereas earlier research compounds in the class, such as \u003ca href=\"\/products\/semaglutide-5mg\"\u003esemaglutide\u003c\/a\u003e (GLP-1) and \u003ca href=\"\/products\/tirzepatide-10mg\"\u003etirzepatide\u003c\/a\u003e (GIP \/ GLP-1), target one or two.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResearch interest:\u003c\/strong\u003e it is a common subject in comparative receptor-pharmacology and metabolic-pathway studies alongside single and dual agonists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHandling:\u003c\/strong\u003e like most research peptides, it is supplied lyophilised for stability and reconstituted in bacteriostatic water for laboratory use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a full research overview, see our \u003ca href=\"\/blogs\/news\/retatrutide-australia-triple-agonist-guide\"\u003eRetatrutide triple agonist research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/aod-9604-australia-fat-loss-research-guide\"\u003eAOD-9604 vs Retatrutide comparison\u003c\/a\u003e. Related compounds: \u003ca href=\"\/products\/tirzepatide-10mg\"\u003eTirzepatide\u003c\/a\u003e, \u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e, \u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e and \u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eWipe the stopper with an alcohol swab, add \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e slowly down the inside wall of the vial, and let the powder dissolve without shaking. Refrigerate at 2–8°C once reconstituted. For worked dilution examples, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003ch3\u003eWhere can I buy Retatrutide in Australia?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies research-grade Retatrutide from Sydney, NSW, with Australia-wide dispatch, AUD pricing and a published COA for every batch.\u003c\/p\u003e\n\u003ch3\u003eIs Retatrutide legal to buy in Australia?\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is not approved by the TGA as a therapeutic good. Optic Labs supplies it strictly as a laboratory research compound, not for human consumption. For an overview of how the TGA treats research peptides, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eIs Retatrutide tested?\u003c\/h3\u003e\n\u003cp\u003eYes. Every batch is third-party HPLC tested, and the Certificate of Analysis is available in our \u003ca href=\"\/pages\/labreport\"\u003eCOA library\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eHow should Retatrutide be stored?\u003c\/h3\u003e\n\u003cp\u003eKeep lyophilised vials at 2–8°C away from light. Once reconstituted, keep refrigerated and use within approximately 28 days. Do not freeze reconstituted stock.\u003c\/p\u003e\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"5mg","offer_id":51462369378529,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":true},{"title":"10mg","offer_id":51462369411297,"sku":null,"price":142.99,"currency_code":"AUD","in_stock":true},{"title":"15mg","offer_id":51462369444065,"sku":null,"price":180.99,"currency_code":"AUD","in_stock":true},{"title":"20mg","offer_id":51462369476833,"sku":null,"price":213.99,"currency_code":"AUD","in_stock":true},{"title":"30mg","offer_id":51462369509601,"sku":null,"price":265.99,"currency_code":"AUD","in_stock":true},{"title":"60mg","offer_id":51462369542369,"sku":null,"price":359.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0867\/4076\/2849\/files\/hf_20260417_081255_f5b56f7b-e33a-4949-bc6f-8bb5bb64109e.png?v=1794373586"},{"product_id":"tirzepatide-10mg","title":"Tirzepatide 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Tirzepatide 10mg in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat is Tirzepatide?\u003c\/strong\u003e Tirzepatide (LY3298176) is a synthetic peptide studied as a dual agonist of the GIP and GLP-1 receptors, widely used as a reference compound in incretin and metabolic receptor research. Optic Labs supplies HPLC-tested Tirzepatide (\u0026gt;99% purity) as a lyophilised 10mg powder vial for laboratory research use only, dispatched Australia-wide from Sydney.\u003c\/p\u003e\n\n\u003ch2\u003eAbout Tirzepatide\u003c\/h2\u003e\n\u003cp\u003eTirzepatide (LY3298176) is a synthetic peptide studied as a dual agonist of the GIP and GLP-1 receptors. As the first widely researched dual incretin receptor agonist, it is a common reference compound in incretin and metabolic receptor research, sitting between single agonists such as \u003ca href=\"\/products\/semaglutide-5mg\"\u003esemaglutide\u003c\/a\u003e and the triple agonist \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies Tirzepatide as a lyophilised (freeze-dried) powder in a sealed 10mg research vial, distributed Australian-domestic from Sydney, NSW. Every batch is independently HPLC tested, and the Certificate of Analysis is published in our \u003ca href=\"\/pages\/labreport\"\u003eCOA library\u003c\/a\u003e. The product is supplied strictly for laboratory research, development or analytical use, not for human or veterinary administration.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Tirzepatide (LY3298176)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClass:\u003c\/strong\u003e GIP \/ GLP-1 receptor dual agonist peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder in sealed research vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVial size:\u003c\/strong\u003e 10mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% (third-party HPLC, COA available)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (lyophilised):\u003c\/strong\u003e 2–8°C, protected from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (reconstituted):\u003c\/strong\u003e 2–8°C, used within approximately 28 days\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReceptor profile:\u003c\/strong\u003e Tirzepatide is studied for its activity at two incretin receptors (GIP and GLP-1) in a single molecule. Researchers often compare it with single GLP-1 agonists and with the GIP \/ GLP-1 \/ glucagon triple agonist \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResearch interest:\u003c\/strong\u003e it is a frequent subject in comparative receptor-pharmacology and metabolic-pathway studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHandling:\u003c\/strong\u003e like most research peptides, it is supplied lyophilised for stability and reconstituted in bacteriostatic water for laboratory use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelated reading: our \u003ca href=\"\/blogs\/news\/retatrutide-australia-triple-agonist-guide\"\u003eRetatrutide triple agonist research guide\u003c\/a\u003e. Related compounds: \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e, \u003ca href=\"\/products\/semaglutide-5mg\"\u003eSemaglutide\u003c\/a\u003e, \u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e and \u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eWipe the stopper with an alcohol swab, add \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e slowly down the inside wall of the vial, and let the powder dissolve without shaking. Refrigerate at 2–8°C once reconstituted. Use our free \u003ca href=\"\/pages\/peptide-calculator\"\u003epeptide calculator\u003c\/a\u003e for concentration maths, and see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003ch3\u003eWhere can I buy Tirzepatide in Australia?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies research-grade Tirzepatide 10mg from Sydney, NSW, with Australia-wide dispatch, AUD pricing and a published COA for every batch.\u003c\/p\u003e\n\u003ch3\u003eIs this the same as a prescription medicine?\u003c\/h3\u003e\n\u003cp\u003eNo. Tirzepatide is the active ingredient in TGA-registered prescription medicines, which are only available through a doctor and pharmacy. The Optic Labs product is a research-grade compound supplied strictly for laboratory research. It is not a medicine and is not for human consumption. For background on how the TGA treats research peptides, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eWhat is the difference between Tirzepatide and Retatrutide?\u003c\/h3\u003e\n\u003cp\u003eTirzepatide is studied as a dual GIP \/ GLP-1 receptor agonist, while \u003ca href=\"\/products\/retatrutide-5mg-10mg-15mg-20mg-30mg-60mg\"\u003eRetatrutide\u003c\/a\u003e is studied as a triple agonist that also acts at the glucagon receptor.\u003c\/p\u003e\n\u003ch3\u003eIs Tirzepatide tested?\u003c\/h3\u003e\n\u003cp\u003eYes. Every batch is third-party HPLC tested, and the Certificate of Analysis is available in our \u003ca href=\"\/pages\/labreport\"\u003eCOA library\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eHow should Tirzepatide be stored?\u003c\/h3\u003e\n\u003cp\u003eKeep lyophilised vials at 2–8°C away from light. Once reconstituted, keep refrigerated and use within approximately 28 days. Do not freeze reconstituted stock.\u003c\/p\u003e\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"10mg","offer_id":51464061878497,"sku":null,"price":159.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0867\/4076\/2849\/files\/hf_20260522_084941_b0c69d65-bc7b-41da-bacb-2a83b2303f06.png?v=1794382619"}],"url":"https:\/\/opticlabsaus.com\/collections\/glp-1-research-peptides.oembed","provider":"Optic Labs","version":"1.0","type":"link"}